Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
51.45
+0.27 (0.53%)
At close: Jul 16, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $327.06 billion as of July 16, 2026. Its market cap has increased by 28.16% in one year.
Market Cap
327.06B
Enterprise Value
354.01B
Revenue
79.90B
Ranking
n/a
PE Ratio
20.13
Stock Price
$51.45
ChartMarket Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 327.06B, an increase of 3,634.05%. That is a compound annual growth rate of 11.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 327.06B | -1.35% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 808.75M |
| Veradigm | 534.05M |
| Silence Therapeutics | 460.53M |
| American Oncology Network | 404.79M |
| Elite Pharmaceuticals | 400.57M |
| Glorywin Entertainment Group | 359.76M |
| CytoDyn | 302.13M |
| Northwest Biotherapeutics | 285.09M |